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Abstract 
ALS is characterised by a focal onset of motor neuron loss, followed by contiguous 
outward spreading of pathology throughout the nervous system, resulting in paralysis 
and death generally within a few years after diagnosis. The aberrant release and 
uptake of toxic proteins including SOD1 and TDP-43 and their subsequent 
propagation, accumulation and deposition in motor neurons may explain such a 
pattern of pathology. Previous work has suggested that internalization of aggregates 
triggers stress granule formation. Given the close association of stress granules and 
TDP-43 we wondered whether internalisation of SOD1 aggregates stimulated TDP-43 
cytosolic aggregate structures. Addition of recombinant mutant G93A SOD1 
aggregates to NSC-34 cells was found to trigger a rapid shift of TDP-43 to the 
cytoplasm where it was still accumulated after 48 hours. In addition, SOD1 
aggregates also triggered cleavage of TDP-43 in to fragments including a 25 kDa 
fragment. Collectively, this study suggests a role for protein aggregate uptake in TDP-
43 pathology. 
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Introduction 
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disorder 
characterized by the loss of both the upper and lower motor neurons in the brain and 
spinal cord respectively, resulting in the progressive paralysis of the muscles of 
speech, limbs, swallowing and respiration, due to the progressive degeneration of 
innervating motor neurons [1]. The neuropathology of all cases of ALS are 
characterised by disease-specific proteins, mutant and wild type alike; mislocalised 
and abnormally accumulated as misfolded, insoluble aggregates in the cytoplasm of 
afflicted motor neurons [2-4]. However, aggregation in ALS is not restricted to 
disease-specific proteins as more than 70 proteins, which have in common the 
biophysical property of being supersaturated, can be found in ALS deposits 
suggesting a collapse of protein homeostasis [5]. Proteinaceous inclusions, containing 
misfolded aggregated proteins, peptides and fragments, also occur in many other 
neurodegenerative disorders including Alzheimer’s disease (AD), Parkinson’s disease 
(PD), frontotemporal dementia (FTD), Huntington’s disease (HD) [6]; and prion 
diseases, such as Creutzfeldt-Jakob disease, Kuru and fatal familial insomnia diseases 
[7, 8]. How misfolded proteins cause cellular dysfunction is unknown, one hypothesis 
is that exposed hydrophobic surfaces interact inappropriately with cellular 
components [9]. 
 
Mutations in several genes cause familial ALS (fALS) which account for 5-10% of 
total ALS cases and contribute to the development of sporadic ALS (sALS, 90% of 
ALS cases) [10]. In fALS, mutations in the gene encoding the Cu/Zn superoxide 
dismutase (SOD1), a ubiquitously-expressed homodimeric enzyme, results in the 
monomerisation [11, 12], misfolding and aggregation of this normally stable protein 
[13]. However, recently misfolded SOD1 species have been increasingly identified in 
non-SOD1 fALS and sALS cases [3, 14], suggesting that misfolded SOD1 may play a 
pathological role in all types of ALS [15]. 
 
In addition to SOD1, TAR DNA binding protein (TDP-43) has been identified as a 
major component of cytoplasmic inclusions in sALS, SOD1-negative fALS and ALS 
with dementia; as well as most common pathological subtype of frontotemporal 
dementia (FTD) with ubiquitinated inclusions [16-21]. However, aggregate formation 
pathways and final structures are likely different between SOD1 and TDP-43 [22]. 
Clinical and pathological overlap between forms of ALS and FTD has raised the 
possibility that there is a pathogenic mechanistic-link between these disorders and has 
prompted their reclassification as TDP-43-proteinopathies. The shared pathology 
includes neuronal cytoplasmic inclusions (NCIs), loss of the normal nuclear TDP-43, 
ubiquitination and hyperphosphorylation of TDP-43 and lastly formation of abnormal 
fragments of TDP-43 in post-mortem tissue [21, 23, 24]. However, TDP-43 is also 
found in inclusions in Machado-Joseph disease [25], spinocerebellar ataxia [26], 
Huntington’s disease [27], Alzheimer’s disease [28], inclusion body myositis [29] and 
Parkinson’s disease [30], suggesting TDP-43 accumulation is not ALS or FTD 
specific. Of interest, AD associated Aβ has been implicated in triggering the 
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phosphorylation and cytosolic accumulation of pathogenic TDP-43 in rodent models 
and in brain autopsies from AD patients [31]. This may explain the presence of TDP-
43 pathology in a proportion of AD cases [32]. Interestingly, the process of 
internalization of tau aggregates triggers stress granule formation and accumulation 
[33], and given that TDP-43 is associated with stress granule formation this may 
explain the accumulation of TDP-43 with other neurodegenerative diseases where 
aggregate propagation is involved in pathology.   
 
 In the current study, we examined whether exogenous recombinant SOD1 protein 
aggregates can induce and/or contribute to TDP-43 pathology, specifically its 
mislocalisation and aggregation. Upon incubation with large recombinantly formed 
SOD1 aggregates with NSC-34 cells, WT TDP-43 was found mislocalised to the 
cytoplasm of both mouse neuronal-like cells and human embryonic kidney cells. We 
also demonstrate that, upon addition of the SOD1 aggregates, fragments of TDP-43 
can be observed in the cytoplasm of NSC-34 cells. Thus, we conclude that addition of 
recombinant SOD1 aggregates to the extracellular environment of neuron like cells in 
culture results in TDP-43 mislocalisation, aggregation and fragmentation. 
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Materials and Methods  
 
Cell Lines  
The mouse neuroblastoma x spinal cord hybrid cell line (NSC34 cells) [34] were 
routinely cultured in DMEM/F-12 supplemented with 10% (v/v) FBS and 2 mM 
GlutaMAX. Cells were maintained in an incubator at 37°C under a humidified 
atmosphere containing 5% (v/v) CO2. Where pCMV6-AC-GFP expression vector 
containing WT TDP43 cDNA was obtained from Origene. pCMV6-AC-tGFP 
expression vector containing TDP43WT cDNA was obtained from Origene. TDP-
tomato red (TdTomato) constructs were created by replacing the EGFP sequences in 
the SOD1-tGFP plasmids with tdTomato (by Genscript, USA). Cells were then 
incubated in DMEM-F-12 serum-free culture medium containing 2 µg WT TDP 
tomato red (TR) plasmid DNA and Lipofectamine 2000 for 5 h at 37°C under a 
humidified atmosphere containing 5% (v/v) CO2. Cells were then washed once with 
serum free media and replenished with complete culture medium. Cells were then 
incubated for a longer period of time either for 19 h, 43 h or 67 h (24 h, 48 h, and 72 h 
in total, respectively). 
 
 
Aggregation of WT and mutant G93A SOD1 
WT and G93A SOD1 were expressed and purified from E.coli as previously outlined 
[35, 36]. SOD1 aggregation was performed in vitro as previously described [35]. 
Briefly, solutions of purified WT or G93A mutant SOD1 protein (1 mg/mL) in PBS 
were co-incubated with 20 mM dithiothreitol (DTT) and 5 mM 
ethylenediaminetetraacetic acid (EDTA) for 72 h at 37°C with shaking using a digital 
shaker (universal IKA® MS 3, 230 V) (Sigma, St. Louis, MO).  
 
Treatment of transfected cells with SOD1 
Cells were visualised prior to experimentation using an Eclipse TE2000 inverted 
microscope (Nikon, Tokyo, Japan) to confirm transfection and determine transfection 
efficiency. NSC34 cells were incubated with labelled biotinylated aggregates, or 
soluble (non-aggregated) WT and mutant G93A SOD1 proteins (20 µg/mL) or no 
protein as a control at 37°C/CO2, for either 2 h or 72 h. Post incubation, cells were 
analysed either by confocal microscopy or FloIT. In the case where cells were 
analysed by confocal microscopy inclusions were counted manually and expressed as 
a proportion of transfected cells. To account for toxicity of the addition of aggregates 
the proportion of cells containing cytoplasmic TDP-43WT tdtomato was normalised to 
the amount of cell loss over 72 hours. To assess the toxicity of SOD1 to cells 
expressing TDP-43WT tdtomato constructs in NSC-34 cells over a time course, an 
IncuCyte® automated fluorescent microscope (Essen BioScience, USA) was used as 
previously described [37]. Briefly, NSC-34 cells were plated into 12-wells plates at a 
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confluency of 60% and were transfected 24 h post-plating. Cells were dissociated 24 
h post-transfection and plated into 96-well plates at a confluency of 20% in phenol-
red-free DMEM-F12 supplemented with 10% FBS. At least 3 images were acquired 
per-well at 2 h intervals for 72 h in both phase and red channels. The number of TDP-
43WT tdtomato positive cells at each time point for each transfection was normalized 
to the intial value determined in the first scan after plating. Then, the normalized 
values of the SOD1 treatments at each time point were divided by the normalized 
TDP-43WT tdtomato alone data at the same time points to determine the relative cell 
viability. The proportion of cells containing cytoplasmic TDP-43WT tdtomato for each 
treatment was then normalised to the relative viability at 72 h. 
 
 
FloIT assay  
The FloIT assay was performed as in previously published work [38]. Briefly, NSC-
34 cells were transiently transfected with TDP-43 (TDP-43WT tdtomato and TDP-
43G124A-EGFP). Following transient transfection at 24h, 48 h and 72h in total, cells 
were harvested and washed using centrifugation. An aliquot of cells (2 x 
105cells/0.15mL) were collected then analysed for transfection efficiency. The 
remaining cells (4 x 105cells/0.35mL) were washed as above and lysed prior to 
analysis in lysis buffer. Cell lysates were then incubated with RedDot2 (1:1000) at RT 
for 2 min. Events were collected using a LSRFortessa X-20 Cell Analyzer (BD 
Biosciences) (excitation 488 nm, emission collected with 525/50 band-pass filter and 
excitation 561, emission collected with 586/15 nm band-pass filter for EGFP and 
RedDot2, respectively). Lysates were firstly gated on forward and side scatter and 
then the fluorescence from RedDot2 were determined by flow cytometry. All 
parameters were set to log10 during acquisition from cell lysates. The forward scatter 
threshold was set to the minimum value (200 AU) to minimise the exclusion of small 
protein inclusions. Nuclei were identified and enumerated based on RedDot2 
fluorescence and forward scatter and then excluded from further analysis. The 
remaining particles were analysed for the presence of inclusions based on GFP/ 
tdTomato fluorescence, forward scatter and comparison lysates prepared from cells 
expressing only the corresponding fluorescent protein. The number of inclusions in 
the population can be normalised to the number of nuclei, and reported as 
inclusions/100 transfected cells (iFloIT) according to the equation outlined in [38]. 
Analysis of all events was determined using FlowJo software (Tree Star, Ashland, 
OR). 
 
Subcellular Fractionation assay of NSC34 cells 
NSC34 cells were incubated with WT SOD1 in a soluble or aggregated form (20 
µg/mL) in PBS for 2 h at 37°C/5% CO2. Post incubation, the cells were washed three 
times with PBS (300 x g for 5 min) harvested using 0.5% trypsin and 5 mM EDTA 
and washed (500 x g for 5 minutes). The cells were washed three times with ice cold 
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PBS (500 x g for 3 minutes) for fractionation using a Subcellular Protein 
Fractionation Kit for Cultured Cells as per manufacturer’s instructions (Thermo 
Fisher Scientific).  
Protein concentration was determined using the BCA method. Supernatants (20 µg 
protein/lane) were separated under reducing conditions (5% β-mercaptoethanol) using 
Any kD Mini-PROTEAN TGX Stain-Free™ Precast Gels. Proteins were then 
transferred to nitrocellulose membranes using a Trans-Blot Turbo Transfer System 
(Bio-Rad). Total protein per lane was then imaged and measured with a Bio-Rad 
Criterion Stain Free Imager and Image Lab software. Membranes were blocked with 
heat denatured casein (HDC) for 1 h at 37°C. To test the purity of the separation, 
rabbit anti-EEA1 pAb (1:500), rabbit anti-Vimentin pAb (1:500) and mouse anti-actin 
mAb (1:5000), diluted in HDC/PBS for 1 h at 37°C were used to probe the ME, NE 
and PE fractions. Membranes were visualised using chemiluminescent substrate and 
Amersham Hyperfilm ECL (GE Healthcare). Images of films were collected using a 
GS-800 Calibrated Densitometer (Bio-Rad). The processing of films was achieved 
using GBX Developer and Replenisher and GBX Fixer and Replenisher (Kodak 
Australiasia, Collingwood, Victoria Australia). Images of the films were collected 
using a GS-800 Calibrated Densitometer (Bio-Rad). 
 
Presentation of data and statistical analyses 
Data is presented as the mean ± SD. ANOVA paired with Tukey’s HSD multiple 
comparison post-test tests were used to analyse and compare differences between 
multiple treatments. Unpaired student’s t-tests were performed for single treatment 
comparisons. Prism 5 for Windows (Version 5.01) (GraphPad Software, San Diego, 
CA) was used to generate these statistical analyses. Differences were defined as 
significant for P < 0.05. 
 
Results 
Transiently expressed TDP-43WT –tdTomato is observed in the cytosol of NSC-34 
cells upon treatment with recombinant SOD1 protein aggregates  
TDP-43 redistribution and aggregation is observed in the cytoplasm of affected cells 
in a diverse set of neurodegenerative diseases. However, the factors responsible for 
TDP-43 mislocalisation and aggregation remain ambiguous. Both SOD1 and TDP-43 
have been implicated in fALS and sALS pathogenesis, although whether SOD1 
misfolding or aggregation contribute to TDP-43 pathology is yet to be established. 
Given Aβ aggregates can affect TDP-43 deposition [31], and uptake of tau aggregates 
causes stress granule formation [33], we tested whether exogenously added SOD1 
aggregates have an effect on TDP-43 cytosolic mislocalisation and aggregation. 
Initially we followed cells transiently expressing WT TDP-43-tomato red (TDP-43WT 
tr) in live cells. Post transfection, cells were incubated with either WT or mutant 
G93A SOD1 in both their aggregated and soluble state (Fig. 1A). The percentage of 
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cells containing cytosolic TDP-43 in foci that measured >1 µm per (this definition 
would include stress granules and inclusions) was determined by confocal 
microscopy. Cytosolic TDP-43 by this definition did not distinguish between cells 
where TDP-43WT was cleared from the nucleus from TDP-43 that had accumulated in 
the cytosol even though some nuclear TDP-43WT remained (Fig. 1B).	Examples of 
TDP-43 morphology scored in this work are given in Fig. 1B. This included a 
granular appearance, large inclusions, with or without clearance of TDP-43 from the 
nucleus. 
 
The addition of SOD1 protein aggregates to NSC-34 cells resulted in a rapid and 
significant increase in percentage of cells that contained cytosolic TDP-43WT when 
treated with SOD1 aggregates (15.6±2%) compared to the controls (absence of 
protein treatment; Fig. 2A). However, there was also a significant increase in cells 
displaying mislocalised TDP-43WT when incubated with soluble G93A SOD1 
(10.4±2%) and soluble WT SOD1 (8.7±2%). Furthermore, little to no cells were 
observed to contain TDP-43WT positive cytoplasmic inclusions without protein 
treatment after the 2 h incubation period. While cells incubated with aggregated 
SOD1 aggregates had more TDP-43WT inclusions than those incubated with soluble 
G93A, no significant differences were detected between them. In contrast, cells 
treated with SOD1 aggregates had significantly more TDP-43WT aggregates when 
compared to cells treated with soluble WT SOD1 (Fig. 2A). 
 
Given TDP-43 translocation can be a rapid response to stress [39] that can be 
reversible [40], we next tested whether the TDP-43WT mislocalisation associated with 
SOD1 aggregate treatment persisted for 72 h. After the extended incubation with 
SOD1 aggregates, a large number of cells still exhibited cytosolic TDP-43WT, which 
appeared as larger clusters of aggregates or inclusion bodies, when assessed by 
confocal microscopy (Fig. 2B).	
 
Incubation of aggregated SOD1 is resulted in a significantly higher percentage of 
transfected cells with miscolcalised TDP-43WT compared to the control cells (Fig. 
2B). In contrast to the 2 h experiment, there was no significant increase in cells 
displaying mislocalised TDP-43WT when incubated with soluble G93A SOD1 and 
soluble WT SOD1. However, it is important to note that complete loss of normal 
nuclear staining was still not observed and that addition of SOD1 aggregates leads to 
a variety of aggregation states (examples shown in Fig. 1B). 
 
Given that the above data relied on manual counting which can be biased by the 
images taken and used for counting, an unbiased and novel flow cytometric (FloIT) 
method was next employed to quantify TDP-43 aggregation after addition of SOD1 
aggregates. Cells were transiently transfected with TDP-43WT-tdTomato and 
incubated with human recombinant G93A mutant SOD1 aggregates for either 24, 48 
or 72 h (Fig. 2C). At each time point, a significant increase in the number of TDP-
43WT inclusions were identified in cells incubated in the presence of mutant SOD1 
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aggregates compared to the corresponding cells in the absence of mutant SOD1 
aggregates (Fig. 2C).  
 
Exogenous recombinant SOD1 aggregates induce the cytosolic mislocalisation 
and fragmentation of endogenous mouse TDP-43 in naive NSC-34 cells. 
Previous work suggests that the accumulation of the truncated TDP-43 fragment 
CTF25 is a pathological feature of TDP-43 proteinopathies [21]. Since this fragment 
has been suggested to play a critical role in ALS pathogenesis, we investigated 
whether adding aggregated SOD1 to NSC-34 cells had any effect on the formation of 
CTF25. We have previously shown that exogenously added recombinant SOD1 is 
capable of entering into NSC-34 cells [41], escaping into the cytosol [42] and causes 
ER stress [43]. To begin to investigate the effect of SOD1 aggregates on endogenous 
TDP-43 location and truncation, a subcellular fractionation assay and western blot 
was carried out on NSC-34 cell lysates (Fig. 3).  
 
TDP-43 location was then investigated by immunoblotting of the cytosolic, 
membrane (ER/Golgi), nuclear and cytoskeletal supernatant fractions (Fig. 3). In the 
SOD1 aggregate-treated fractions (Fig. 3A), TDP-43 was detected as a range of bands 
but predominantly as distinct bands at 43 kDa and ~25 kDa in all fractions to some 
degree. In contrast, in untreated controls and cells treated with soluble SOD1, TDP-43 
was found predominantly in the nuclear fraction (Fig. 3B,C). In samples treated with 
aggregates, there were also bands found in the membrane fraction at approximately 40 
kDa and 18 kDa. The additional 40 kDa band was also detected in the nuclear (N) and 
cytoskeletal (P) fractions at much lower levels. Interestingly, after treatment with 
SOD1 aggregates the full length mouse TDP-43 was predominantly cytosolic and 
associated with the membrane fraction suggesting a rapid movement from the nucleus 
after SOD1 aggregate addition. This was in contrast to the work presented above 
which shows that only a proportion of TDP-43WT-tdTomato becomes cytosolic after 
SOD1 incubation. This is likely to be due to the fact that we are overexpressing 
human TDP-43  in that system. To further confirm the purity of the fractions, control 
immunoblotting using an anti-actin, anti-EEA1 and anti-vimentin antibody was 
performed (Fig. 3D). These bands were detected in the membrane fraction for EEA1 
(180 kDa), and cytoskeleton fraction for vimentin (54 kDa), while actin (42 kDa) 
acted as a loading control and could be found in all fractions.  
 
 
Discussion 
Mutations in the TDP-43 gene are found in sporadic and familial ALS, implicating 
TDP-43 as a contributing factor to disease [44, 45]. TDP-43 has previously been 
reported to spontaneously form aggregates that resemble TDP-43 deposits in 
degenerating neurons in ALS FTD-U patients [46]. Furthermore, previous studies 
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have reported that in the TDP-43 protein sequence, the C-terminal domain is critical 
for spontaneous aggregation and that TDP-43 is intrinsically aggregation prone [46].  
 
Consistent with misfolded SOD1 detected in sALS, previous work has demonstrated 
that WT SOD1 misfolding can be propagated cell to cell [41], at least partly due to 
protein aggregate uptake via macropinocytosis, subsequent stress and protein 
aggregation [42, 43, 47]. Further, internalization of tau aggregates was found to 
stimulate stress granule formation and accumulation [33].  Here we have shown that 
exogenously added large SOD1 protein aggregates are capable of inducing the 
cytoplasmic mislocalisation and accumulation of TDP-43 in the motor neuron-like 
cell line (NSC- 34). Furthermore, the present study demonstrates that the addition of 
large SOD1 aggregates induces rapid fragmentation of TDP-43 in the cytoplasmic 
fraction of NSC-34 cells. Collectively, this suggests that exogenous protein 
aggregates are capable of stimulating TDP-43 pathology through an unknown 
mechanism(s), resulting in their redistribution, fragmentation and aggregation, similar 
to what has been observed in most cases of ALS [15, 23, 48, 49]. 
 
An association between misfolded and/or aggregated SOD1 and TDP-43 
mislocalisation has been previously suggested. For example, a study has reported that 
TDP-43 cytoplasmic mislocalisation and deposition into ubiquitin immunoreactive 
inclusions were observed in lower motor neurons of end stage mutant SOD1 
transgenic mice [50]. In addition to this, misfolded human WT SOD1 has been 
observed in association with a cytosolic accumulation of mutant TDP-43 in TDP-43-
fALS and WT TDP-43 in sALS [15]. It has been suggested that mutant TDP-43 may 
indirectly induce the propagation of WT SOD1 misfolding in fALS and sALS [15]. 
Given that the aggregation of TDP-43 and SOD1 appear to be distinct processes with 
structurally and morphologically discrete aggregates [22], it is unlikely that one will 
seed aggregation of the other in a conventional manner and therefore must be 
explained by an alternate mechanism.  
 
Cytoplasmic accumulation of WT TDP-43 as a local response to injury or cell stress 
has been previously described in sALS [40]. In addition to this, misfolded and 
aggregated SOD1 can induce ER stress and dysfunction and stress granule formation 
in cell culture [51], rodent ALS models at symptom onset and disease end stage and 
human ALS patients [52-56]. There is evidence that the uptake of extracellular 
misfolded WT and mutant G93A SOD1 into human and mouse neuronal cells causes 
disruptions to protein transport between the ER and Golgi apparatus, resulting in ER 
stress, Golgi fragmentation, and subsequent apoptotic cell death [43]. ER stress is 
activated when proteins accumulate within the ER lumen, thus triggering the unfolded 
protein response (UPR), which in turn may lead to cellular apoptosis if unresolved 
[57]. There is a strong link between ALS pathology and ER stress [58] and it has 
been proposed that prolonged ER stress leads to motor neuron death in ALS [58]. 
While generally the unfolded protein response activated by ER stress is a protective 
response able to rescue cells from proteotoxicity, in the ALS context this can lead to 
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further aggregation of ALS associated proteins such as TDP-43 [59]. Taken together, 
these data are consistent with the idea that ER stress caused by uptake and 
maintenance of SOD1 aggregates may trigger TDP-43 mislocalisation and 
accumulation. In the case that uptake of protein aggregates into neurons causes TDP-
43 mislocalisation and inclusion formation, it may be possible to inhibit this process 
by suppressing the uptake of aggregates. This may be possible by utilising molecular 
chaperones or manipulating macropinocytosis pathways. 
 
TDP-43 mislocalisation is a common response to a variety of stressors including 
oxidative stress [60], heat shock stress [61], and proteosomal stress [62]. Indeed 
extranuclear accumulation of WT TDP43 has been shown to be a common pathology 
in sALS, FTD and Alzheimer’s disease, and therefore may be a general consequence 
of cellular stress [32]. Interestingly, exogenously applied Aβ amyloid aggregates 
associated with Alzheimer’s disease have also been shown to induce TDP-43 
mislocalisation [31] suggesting that uptake of any aggregate regardless of which 
protein they are made from might be enough to trigger TDP-43 accumulation. This 
widespread predisposition of various types of neurons to undergo cytosolic 
accumulation of TDP-43 may be a consequence of the generally low protesostasis 
capacity of neurons [63].  
   
Conclusion  
In conclusion, the work presented here presents findings to suggest that aggregates 
made from SOD1 are able to induce TDP-43 mislocalisation and rapid fragmentation 
consistent with TDP pathology observed in sporadic disease. However, the exact 
mechanism(s) for this observation were not determined. It is likely that the stress 
induced by aggregate uptake was enough to trigger the mislocalisation of TDP-43. 
However, it should be noted that a high concentration (20 µg/ml) of large SOD1 
protein aggregates were used in the current study to induce TDP-43 pathology in cell 
lines. This concentration is higher than that used in a number of similar studies [64, 
65]. Future investigations into the mechanism(s)/role of SOD1 aggregates on the 
formation of pathological TDP43 are therefore warranted. 
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Figure 1. Treatment of NSC-34 cells with large SOD1 protein aggregates. (A) 
Schematic diagram of experimental outline; recombinant human SOD1 was 
aggregated (followed by ThT fluorescence), or not, and then added to NSC-34 cells 
expressing TDP-43WT-TR. TEM bar represents 50 nm. (B) TDP-43 mislocalisation 
was initially determined by manually counting fluorescent foci larger than 1 µm; 
various examples of TDP-43 structures scored as mislocalised are shown here. Bars 
represent 10 µm.	
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Figure 2. Exogenous recombinant SOD1 aggregates induce TDP43 
mislocalisation and aggregation. The percentage of NSC34 cells containing 
TDP43WT positive aggregates was assessed by the number of cells containing 
mislocalised TDP43 into foci that measured >1µm per treatment including both 
TDP43WT cleared from the nucleus and TDP43WT that had accumulated in the cytosol 
even though some nuclear TDP43WT remained, as determined by Image J. Results 
shown for 2 h (A) and 72 h (B) as means ± SD, n = 3; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 
0.001.	Example Confocal images of TDP-43 pathology from respective time points. 
Bars represent 25 µm. (C) FloIT analysis of cell lysates. Following transfection (24, 
48 and 72 h), adherent NSC-34 cells transiently transfected with TDP-43WT were co-
cultured with 20 µg/ml and aggregated G93A SOD1 for indicated time intervals at 
37°C. Cells were harvested for supernatant analysis and then lysed. Cell lysates were 
incubated with RedDot2 for 2 min at RT. Transfection efficiencies, the number of 
inclusions and nuclei were determined by flow cytometry and results means ± SD, n = 
3, *P < 0.05 compared to corresponding control (no protein treatment).   
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Figure 3. Exogenous recombinant SOD1 proteins induce TDP43 fragmentation 
and cytosolic mislocalisation in NSC34 cells. Cytoplasmic extract (C), membrane 
extract (ER/Golgi) (M), nuclear extract (N) and pellet extract (cytoskeleton) (P) 
fractions by centrifugation from NSC-34 cells treated with either (A) SOD1 
aggregates or (B) WT SOD1 soluble (20 µg/mL) or (C-D) no added protein were 
separated by SDS PAGE under reducing conditions, transferred to nitrocellulose 
membrane and incubated with anti-TDP43, anti-actin, anti-EEA1 or anti-vimentin 
Abs (as indicated).   
 
	
	
	
	
	
